Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation
2010

Using Stem Cells to Improve Islet Transplantation

Sample size: 13 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ida Duprez, Ulrika Rasmusson, Bo Nilsson, Olle Korsgren, Peetra U. Magnusson

Primary Institution: Uppsala University, Department of Oncology, Radiology and Clinical Immunology

Hypothesis

Can human mesenchymal stem cells (MSCs) enhance the success of pancreatic islet transplantation?

Conclusion

The study shows that MSCs can effectively coat pancreatic islets and may help in reducing immune reactions during transplantation.

Supporting Evidence

  • MSCs adhered to islets and spread to cover their surface.
  • Insulin secretion was maintained in MSC-coated islets.
  • MSCs suppressed lymphocyte proliferation in mixed lymphocyte reactions.

Takeaway

Scientists are trying to use special cells called stem cells to help make insulin-producing cells last longer when they are transplanted into people.

Methodology

The study involved co-culturing human MSCs with islets, assessing their adhesion, insulin release, and immune response in vitro.

Potential Biases

Potential bias in the selection of MSCs and islet sources could affect the results.

Limitations

The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.

Participant Demographics

Human donors for islets and MSCs were used, but specific demographic details were not provided.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3109/03009734.2010.524320

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication